Changeflow GovPing Pharma & Drug Safety Patent EP4507726A1: Arginine formulations with ...
Routine Notice Added

Patent EP4507726A1: Arginine formulations with PD-1 antibody

Email

Summary

Patent EP4507726A1: Arginine formulations with PD-1 antibody

Source document (simplified)

← EPO Patent Bulletin

STABLE HIGH CONCENTRATION ARGININE FORMULATIONS CONTAINING PD-1 ANTIBODY AND METHODS OF USE THEREOF

Publication EP4507726A1 Kind: A1 Mar 18, 2026

Applicants

BeiGene Switzerland GmbH

Inventors

JIN, Xiaoqing, JI, Yu, GU, Sufang, SHEN, Jian, QIU, Bo, WU, Jun

IPC Classifications

A61K 39/395 20060101AFI20231020BHEP A61K 39/00 20060101ALI20231020BHEP C07K 16/18 20060101ALI20231020BHEP A61K 47/26 20060101ALI20231020BHEP C07K 14/705 20060101ALI20231020BHEP C07K 16/00 20060101ALI20231020BHEP A61P 35/00 20060101ALI20231020BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.